Peijia Medical Ltd. (HK:9996) has released an update.
Peijia Medical Ltd., through its subsidiary Achieva Medical, has secured an exclusive eight-year distribution agreement with Jiangsu NowYon Medical for the YonFlow flow diverter, a novel medical device for neurovascular interventions in Greater China. The YonFlow device, which is awaiting approval by the National Medical Products Administration, represents a strategic enhancement to Peijia’s neurointerventional product offerings, aiming to reinforce its market position in China.
For further insights into HK:9996 stock, check out TipRanks’ Stock Analysis page.
